Lucid Tala vs Otofonix Encore

The Lucid Tala is a premium-priced OTC hearing aid at $1,300, earning an A grade with a SoundScore of 4.6/5 in our lab testing. Ranking #4 among 65 OTC hearing aids tested, it places in the top 5% of its category and has received HearAdvisor's Expert's Choice Award in both 2023 and 2024. Speech performance is a clear strength. Speech in Quiet scores an excellent 4.6/5, measuring 1.85 points above the category average. Speech in Noise reaches a solid 3.0/5, which is 1.56 points above the OTC average of 1.48—a meaningful advantage for conversations in challenging environments. Music streaming also performs well at 3.0/5, exceeding the category average by 1.08 points. The primary weakness is feedback handling, which scores a low 1.7/5 in our tuned testing—2.84 points below the category average of 4.54. This suggests users may experience more whistling or feedback artifacts than typical OTC devices. Own-voice comfort is mixed at 2.6/5, sitting just above the category average but not standing out in absolute terms. The Lucid Tala is best suited for users who prioritize speech clarity and are willing to pay premium OTC pricing for strong intelligibility performance. Those highly sensitive to feedback may want to consider alternatives. At this price point, comparable options include the Audicus Omni 2, though budget-conscious shoppers might explore lower-priced devices like the Elehear Beyond or Yeasound RIC700, which also deliver strong sound performance in our testing.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.